Ashoka: Traditional Use, Evidence & Safety

TL;DR

I have read the ashoka trials, and here is where I land. The strongest evidence is a 363-woman trial of a neem–ashoka vaginal tablet for leucorrhea, and it performed well. But nobody has tested single-herb ashoka bark in a human trial. The center of this page is an evidence gap.

What it is

Ashoka is the stem bark of Saraca asoca (Roxb.) de Wilde, an evergreen tree in the Fabaceae (legume) family. Older pharmacological literature calls the same plant Saraca indica. For example, the 1970 Indian Journal of Medical Research report on its uterine activity uses that name (Satyavati et al., as indexed in the JBCPP reference list).

A peer-reviewed pharmacology paper describes Ashok as "a popular traditional plant used for gynecological disorders" (Swar et al., J Ethnopharmacol 2017). The bark is the part tested in the pharmacological studies reviewed below, and S. asoca is also the base of the traditional fermented preparation Asokarishta (Ashokarishta), described in the literature as a uterine tonic used in Ayurveda (J Basic Clin Physiol Pharmacol, DOI 10.1515/jbcpp-2014-0124). Two names, one tree. Keep them straight, because the literature switches between them freely.

Traditional use

These are records of traditional practice, not clinical proof. I repeat that because the next section is where people will be tempted to blur the line, and the trial evidence is assessed separately below, strictly on its own.

What modern research says

Leucorrhea: one double-blind RCT — of a two-herb vaginal tablet, not ashoka alone

The headline trial is real and its numbers are verifiable, but it did not test ashoka by itself. I will keep saying that, because every oversell of this herb starts by forgetting it.

Gupta et al. ran a double-blind randomized trial in 363 women with leucorrhea/vaginitis, divided into six groups (placebo, standard drug, and four research-drug groups) for 15 days (journal abstract page). The research product was a mucoadhesive extended-release **vaginal tablet combining dried stems of neem (Azadirachta indica) and Saraca asoca in equal parts, a hydro-alcoholic extract standardized by the investigators. All four research groups showed comparable and sometimes better efficacy than the standard drug, with 80–90% inhibition of subjective symptoms** and statistically significant antimicrobial action (p < 0.05).

Honest caveats: (1) this is a two-herb combination, and neem bark has its own well-known antimicrobial activity, so ashoka's individual contribution cannot be isolated. (2) it is a single trial in a niche journal, verified here from the journal's abstract page rather than the full text; (3) a 15-day vaginal-tablet study says nothing about oral ashoka bark for heavy periods. I would not let a retailer quote this trial on a bottle of ashoka bark powder.

Heavy menstrual bleeding: one small comparative study of Ashokarishta — no placebo

A prospective comparative study (n=60) treated women with Asrigdara, the Ayurvedic correlate of heavy/prolonged menstrual bleeding, with either Asokarista or Pradarantak Lauha for three menstrual cycles. Both groups showed significant reductions in symptom scores (p < 0.001) (Maiti, J Ayurveda Integr Med Sci). With no placebo or standard-care arm and no blinding, the improvement cannot be separated from time, placebo, or the other formula's ingredients.

One thing to watch: a registered randomized protocol (CTRI/2023/05/052929) is testing Ashokarishta plus Trinakantamani pishti against tranexamic acid for menorrhagia; the protocol projected data analysis by February 2026 (protocol, PubMed 40163851). As of September 2026, no results have been published. That is the trial this herb actually needs. We do not have it yet.

Single-herb ashoka bark: no high-quality human trial

Every human study located tests a formulation: a neem–ashoka vaginal tablet, Asokarista, or Ashokarishta-based regimens. The plain bark that Ayurveda prizes has never been tested against placebo or standard care in humans for any gynecological condition. That is the central evidence gap, stated plainly. I have searched for the exception. There isn't one.

Preclinical findings: uterine and anti-inflammatory signals (animal studies)

These are animal and laboratory findings. They suggest mechanisms worth testing in humans, not treatments. And note the tension I am not going to resolve for you: estrogenic in one study, anti-estrogenic in another. That is what thin, unreplicated animal literature looks like.

What the evidence does not support (yet)

No human evidence supports using single-herb ashoka bark for menorrhagia, dysmenorrhea, fibroids, endometriosis, or fertility. Formula studies cannot be read as proof for the bark alone, and the one strong RCT tested a neem–ashoka combination product. The gap between what is claimed on labels and what has been tested is the widest on this page.

Dosage

There is no established dose for single-herb ashoka bark. No clinical trial has tested the bark alone, so no dose-finding exists. The regimens in the literature belong to formulations: a vaginal tablet in the Gupta leucorrhea trial and Ashokarishta-based regimens in the comparative study and the registered menorrhagia protocol. Do not extrapolate a personal dose from any of these.

Safety & contraindications

Human safety data for ashoka are limited to what small trials report, and the Gupta trial's abstract page does not report adverse events. In animals, the flower extract was safe at a single oral dose of 2000 mg/kg in rats under OECD acute-toxicity guidelines, an animal limit test, not a human safety endorsement (Swar et al.).

Given the preclinical signals of uterine activity (estrogenic/anti-estrogenic effects, an early oxytocic report), ashoka should not be used to self-treat heavy menstrual bleeding, which can have serious underlying causes, without medical evaluation. I mean that as a hard line, not a suggestion. Consult a qualified practitioner before use, especially in pregnancy or alongside hormonal medicines.

FAQs

What is ashoka used for in Ayurveda?

Ashoka (Saraca asoca) is Ayurveda's classic uterine remedy. Traditional sources use the plant for gynecological disorders including excessive vaginal discharge (an ashoka–neem combination is mentioned in the Charak Samhita for that purpose), and its fermented preparation Asokarishta is used as a uterine tonic (Gupta et al. 2020; JBCPP, DOI 10.1515/jbcpp-2014-0124). Traditional use is not clinical proof. I keep both facts in the same paragraph on purpose.

Does the 363-woman trial prove ashoka works for leucorrhea?

No. It proves something narrower, and narrower is still interesting. The trial tested a neem–ashoka vaginal tablet (equal parts of both barks) against placebo and a standard drug, and the combination performed well (Gupta et al. 2020). Because neem has its own antimicrobial activity, ashoka's individual contribution cannot be isolated from this study.

Has ashoka bark alone ever been tested in a clinical trial?

Not to any credible standard. Every human study located tests a formulation: the neem–ashoka vaginal tablet, Asokarista, or Ashokarishta-based regimens. No published trial has tested plain ashoka bark against placebo or standard care. That is the sentence this entire article orbits.

What is Ashokarishta?

Ashokarishta (also spelled Asokarista) is the traditional fermented preparation of Saraca asoca, used in Ayurveda as a uterine tonic (JBCPP, DOI 10.1515/jbcpp-2014-0124). It was compared against another Ayurvedic formula for heavy bleeding in one small unblinded study, and a registered RCT against tranexamic acid had published no results as of September 2026 (Maiti, JAIMS; protocol, PubMed 40163851).

Is ashoka safe?

Human safety data are limited. An animal study found no toxicity at a single 2000 mg/kg oral dose in rats, and the one RCT's abstract page reports no adverse events, but neither establishes human safety (Swar et al.; Gupta et al. 2020). Given preclinical uterine-activity signals, do not use it to self-treat heavy bleeding without medical evaluation, and consult a qualified practitioner first, especially in pregnancy or with hormonal medicines. "Limited data" is not a clearance.

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use, especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.